Cooper Companies, Inc. (COO): EBITDA
$1.06B
Year ended 2025-10-31
$928.20M
Trailing 12 months to 2026-07-31
+7.5%
3-year compound annual growth
+9.5%
10-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-10-31 | $1.06B | -1.9% | 2025-12-05, From 2024-11-01 |
| 2024-10-31 | $1.08B | +20.0% | 2025-12-05, From 2023-11-01 |
| 2023-10-31 | $900.80M | +5.5% | 2025-12-05, From 2022-11-01 |
| 2022-10-31 | $853.70M | +4.7% | 2024-12-06, From 2021-11-01 |
| 2021-10-31 | $815.10M | n/a | 2023-12-08, From 2020-11-01 |
| No annual figure between 2019-10-31 and 2021-10-31. | |||
| 2019-10-31 | $827.50M | +22.0% | 2021-12-10, From 2018-11-01 |
| 2018-10-31 | $678.20M | +9.8% | 2020-12-11, From 2017-11-01 |
| 2017-10-31 | $617.50M | +18.2% | 2019-12-20, From 2016-11-01 |
| 2016-10-31 | $522.40M | +22.0% | 2018-12-21, From 2015-11-01 |
| 2015-10-31 | $428.10M | -3.7% | 2017-12-22, From 2014-11-01 |
| 2014-10-31 | $444.69M | +3.1% | 2016-12-22, From 2013-11-01 |
| 2013-10-31 | $431.29M | +9.3% | 2015-12-18, From 2012-11-01 |
| 2012-10-31 | $394.61M | +21.2% | 2014-12-19, From 2011-11-01 |
| 2011-10-31 | $325.70M | +14.7% | 2013-12-20, From 2010-11-01 |
| 2010-10-31 | $283.91M | +17.1% | 2012-12-20, From 2009-11-01 |
| 2009-10-31 | $242.46M | +15.9% | 2011-12-16, From 2008-11-01 |
| 2008-10-31 | $209.15M | n/a | 2010-12-17, From 2007-11-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Cooper Companies, Inc. (COO) | 2025-10-31 | $1.06B | -1.9% |
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $534.00M | -10.7% |
| National Vision Holdings, Inc. (EYE) | 2026-01-03 | $149.98M | +85.2% |
| Warby Parker Inc. (WRBY) | 2025-12-31 | $44.94M | +185.3% |
| RxSight, Inc. (RXST) | 2025-12-31 | -$44.92M | n/m |
Compare COO, BLCO, EYE, WRBY side by side · Screen every company in Ophthalmic Goods ↗